Aveanna Healthcare Holdings, Inc.

Health Care
Medical/Nursing Services
www.aveanna.com

Market Cap $1.01B
Debt $1.32B
Cash $78.46M
EV $2.25B
FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$65.85M
EBIT	$123.31M
ROA	7%
Equity	-$156.44M
Growth Stability	1
PE	-15.34
PB	-6.46
P/S	0.51
Price/Cash	0.08
Debt/Equity	-8.43
Net Margins	-3%
Gross Margins	31%
Op. Margins	6%
Sales Growth YoY	6%
Sales Growth QoQ	1%
Sales CAGR	7%
FCF CAGR	-1%
Equity CAGR	1%
Earnings Growth YoY	-58%
Earnings Growth QoQ	-408%

Sales CAGR 5Y	7%
FCF CAGR 5Y	-1%
Equity CAGR 5Y	1%
Earnings CAGR 3Y	6%
Sales CAGR 3Y	6%
Equity CAGR 3Y	-2%
Market Cap	$1.01B
Revenue	$1.98B
Assets	$1.64B
Total Debt	$1.32B
Cash	$78.46M
Shares Outstanding	192.73M
EV	2.25B
Working Capital	-24.67M
Current Ratio	0.94
Gross Profit	$612.27M
Shares Growth 3y	3%
Equity Growth QoQ	31%
Equity Growth YoY	48%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Aveanna Healthcare Holdings Inc is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients. The company provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS).

SEC Filings

Direct access to Aveanna Healthcare Holdings, Inc. (AVAH) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 28
- 10-Q Jun 29
- 10-Q Mar 30
2023
- 10-K Dec 30
- 10-Q Sep 30
- 10-Q Jul 01
- 10-Q Apr 01
2022
- 10-K Dec 31
- 10-Q Oct 01
- 10-Q Jul 02
- 10-Q Apr 02
- 10-K Jan 01

Sector Comparison

How does Aveanna Healthcare Holdings, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Aveanna Healthcare Holdings, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Aveanna Healthcare Holdings, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Aveanna Healthcare Holdings, Inc..

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
DCF		$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Value	$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2019	01/2021	12/2021	12/2022	12/2023	TTM
Net Margins	-6%	-4%	-7%	-37%	-7%	-3%
ROA	-	-0%	-2%	-38%	1%	7%
ROE	-	-22%	-18%	10K%	104%	-

Bad Net Margins (-2.67%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2019	01/2021	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	12.04	-46.94	-	-	-
Debt over Equity	-	4.6	2.02	-211.28	-10.22	-8.43
Growth Stability	-	-	-	-	-	1

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (-8.43)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2019	01/2021	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	8%	12%	6%	6%	7%
Earnings YoY growth	-	-25%	105%	466%	-80%	-
Equity YoY growth	-	-2%	140%	-101%	2K%	1%
FCF YoY growth	-	-500%	-127%	-	-	-1%